BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

466 related articles for article (PubMed ID: 27533464)

  • 21. Loss of α1,6-fucosyltransferase inhibits chemical-induced hepatocellular carcinoma and tumorigenesis by down-regulating several cell signaling pathways.
    Wang Y; Fukuda T; Isaji T; Lu J; Im S; Hang Q; Gu W; Hou S; Ohtsubo K; Gu J
    FASEB J; 2015 Aug; 29(8):3217-27. PubMed ID: 25873065
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MicroRNA-708 is downregulated in hepatocellular carcinoma and suppresses tumor invasion and migration.
    Li G; Yang F; Xu H; Yue Z; Fang X; Liu J
    Biomed Pharmacother; 2015 Jul; 73():154-9. PubMed ID: 26211597
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MiR-199a-5p suppresses tumorigenesis by targeting clathrin heavy chain in hepatocellular carcinoma.
    Huang GH; Shan H; Li D; Zhou B; Pang PF
    Cell Biochem Funct; 2017 Mar; 35(2):98-104. PubMed ID: 28261837
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MicroRNA-379-5p inhibits tumor invasion and metastasis by targeting FAK/AKT signaling in hepatocellular carcinoma.
    Chen JS; Li HS; Huang JQ; Dong SH; Huang ZJ; Yi W; Zhan GF; Feng JT; Sun JC; Huang XH
    Cancer Lett; 2016 May; 375(1):73-83. PubMed ID: 26944318
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MicroRNA-486-5p, which is downregulated in hepatocellular carcinoma, suppresses tumor growth by targeting PIK3R1.
    Huang XP; Hou J; Shen XY; Huang CY; Zhang XH; Xie YA; Luo XL
    FEBS J; 2015 Feb; 282(3):579-94. PubMed ID: 25475121
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MicroRNA-34c-3p promotes cell proliferation and invasion in hepatocellular carcinoma by regulation of NCKAP1 expression.
    Xiao CZ; Wei W; Guo ZX; Zhang MY; Zhang YF; Wang JH; Shi M; Wang HY; Guo RP
    J Cancer Res Clin Oncol; 2017 Feb; 143(2):263-273. PubMed ID: 27704267
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MiR-200c-5p suppresses proliferation and metastasis of human hepatocellular carcinoma (HCC) via suppressing MAD2L1.
    Li Y; Bai W; Zhang J
    Biomed Pharmacother; 2017 Aug; 92():1038-1044. PubMed ID: 28609841
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hepatocellular carcinoma-associated mesenchymal stem cells promote hepatocarcinoma progression: role of the S100A4-miR155-SOCS1-MMP9 axis.
    Yan XL; Jia YL; Chen L; Zeng Q; Zhou JN; Fu CJ; Chen HX; Yuan HF; Li ZW; Shi L; Xu YC; Wang JX; Zhang XM; He LJ; Zhai C; Yue W; Pei XT
    Hepatology; 2013 Jun; 57(6):2274-86. PubMed ID: 23316018
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MicroRNA-340 inhibits the proliferation and invasion of hepatocellular carcinoma cells by targeting JAK1.
    Yuan J; Ji H; Xiao F; Lin Z; Zhao X; Wang Z; Zhao J; Lu J
    Biochem Biophys Res Commun; 2017 Jan; 483(1):578-584. PubMed ID: 27998770
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MicroRNA-98 acts as a tumor suppressor in hepatocellular carcinoma via targeting SALL4.
    Zhou W; Zou B; Liu L; Cui K; Gao J; Yuan S; Cong N
    Oncotarget; 2016 Nov; 7(45):74059-74073. PubMed ID: 27677076
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MicroRNA-24 increases hepatocellular carcinoma cell metastasis and invasion by targeting p53: miR-24 targeted p53.
    Chen L; Luo L; Chen W; Xu HX; Chen F; Chen LZ; Zeng WT; Chen JS; Huang XH
    Biomed Pharmacother; 2016 Dec; 84():1113-1118. PubMed ID: 27780140
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MicroRNA-519a promotes tumor growth by targeting PTEN/PI3K/AKT signaling in hepatocellular carcinoma.
    Tu K; Liu Z; Yao B; Han S; Yang W
    Int J Oncol; 2016 Mar; 48(3):965-74. PubMed ID: 26708293
    [TBL] [Abstract][Full Text] [Related]  

  • 33. miR-22 targets YWHAZ to inhibit metastasis of hepatocellular carcinoma and its down-regulation predicts a poor survival.
    Chen M; Hu W; Xiong CL; Qu Z; Yin CQ; Wang YH; Luo CL; Guan Q; Yuan CH; Wang FB
    Oncotarget; 2016 Dec; 7(49):80751-80764. PubMed ID: 27811373
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MiRNA expression profiles reveal the involvement of miR-26a, miR-548l and miR-34a in hepatocellular carcinoma progression through regulation of ST3GAL5.
    Cai H; Zhou H; Miao Y; Li N; Zhao L; Jia L
    Lab Invest; 2017 May; 97(5):530-542. PubMed ID: 28218742
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MicroRNA-26a suppresses epithelial-mesenchymal transition in human hepatocellular carcinoma by repressing enhancer of zeste homolog 2.
    Ma DN; Chai ZT; Zhu XD; Zhang N; Zhan DH; Ye BG; Wang CH; Qin CD; Zhao YM; Zhu WP; Cao MQ; Gao DM; Sun HC; Tang ZY
    J Hematol Oncol; 2016 Jan; 9():1. PubMed ID: 26733151
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of cell proliferation and metastasis of human hepatocellular carcinoma by miR-137 is regulated by CDC42.
    Gao M; Liu L; Li S; Zhang X; Chang Z; Zhang M
    Oncol Rep; 2015 Nov; 34(5):2523-32. PubMed ID: 26352279
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MicroRNA-98 suppresses cell proliferation, migration and invasion by targeting collagen triple helix repeat containing 1 in hepatocellular carcinoma.
    Wang CY; Zhang JJ; Hua L; Yao KH; Chen JT; Ren XQ
    Mol Med Rep; 2016 Mar; 13(3):2639-44. PubMed ID: 26846175
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Direct targeting sperm-associated antigen 9 by miR-141 influences hepatocellular carcinoma cell growth and metastasis via JNK pathway.
    Lou G; Dong X; Xia C; Ye B; Yan Q; Wu S; Yu Y; Liu F; Zheng M; Chen Z; Liu Y
    J Exp Clin Cancer Res; 2016 Jan; 35():14. PubMed ID: 26790956
    [TBL] [Abstract][Full Text] [Related]  

  • 39. miR-503 regulates metastatic function through Rho guanine nucleotide exchanger factor 19 in hepatocellular carcinoma.
    Zhou J; Tao Y; Peng C; Gu P; Wang W
    J Surg Res; 2014 May; 188(1):129-36. PubMed ID: 24405610
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MicroRNA-122, a tumor suppressor microRNA that regulates intrahepatic metastasis of hepatocellular carcinoma.
    Tsai WC; Hsu PW; Lai TC; Chau GY; Lin CW; Chen CM; Lin CD; Liao YL; Wang JL; Chau YP; Hsu MT; Hsiao M; Huang HD; Tsou AP
    Hepatology; 2009 May; 49(5):1571-82. PubMed ID: 19296470
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.